3Massion PB, Feron O, Dessy C, et al. Nitric oxide and cardiac function : ten years after ,and continuing. Circ Res, 2003,93: 388-398.
4Dzau V J, Mann M J,Ehsan A, et al. Gene therapy and genomic strategies for cardiovascular surgery :the emerging field of surgiomies.J Thorac Cardiovase Surg, 2001,121 : 206-216.
5Alexander RW, Dzau VJ.Vascular biology: the past 50 year.Circulation, 2000,102 (20 Suppl 4): IV112-IV116.
6Cable DG, OBrien T, Kullo IJ, et al. Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries. Cardiovasc Res,1997,35:553-559.
7Chiu-Pinheiro CK, O'Brien T, Katusic ZS, et al. Gene transfer to coronary artery bypass conduits. Ann Trorac Surg, 2002,74 : 1161-1166.
9Cable DG, Ol3rien T, Schaff HV, et al. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits.Circulation, 1997 ,96 (9 Suppl) :Ⅱ-173-178.
10Cable DG, Caccitolo JA, Caplice N, et al. The role of gene therapy for intimal hyperplasia of bypass graft. Circulation, 1999, 100 (19 Suppl) :II392-396.
